Christopher H. Hunter - 01 Sep 2021 Form 4 Insider Report for HUMANA INC (HUM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Sep 2021, 09:00:34 UTC
Prior SEC filing
11 Aug 2021
Next SEC filing
13 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Christopher H. Hunter

Key filing fact

Christopher H. Hunter filed Form 4 for HUMANA INC (HUM) on 01 Sep 2021.

Key facts

  • This page summarizes Christopher H. Hunter's Form 4 filing for HUMANA INC (HUM).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 01 Sep 2021, 09:00.

Change

  • Previous filing in this sequence was filed on 11 Aug 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUM holding

Humana Common

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,168
Date
01 Sep 2021
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
459
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
459
Exercise price
$217.42
Footnotes
F1
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,623
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
6,623
Exercise price
$268.47
Footnotes
F2
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,106
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
6,106
Exercise price
$307.96
Footnotes
F3
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,088
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
6,088
Exercise price
$350.79
Footnotes
F4
HUM holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,598
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
4,598
Exercise price
$376.61
Footnotes
F5
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
460
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
460
Exercise price
Footnotes
F6, F8
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
808
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
808
Exercise price
Footnotes
F7, F9
HUM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,117
Date
01 Sep 2021
Ownership
Direct
Underlying class
Humana Common
Underlying amount
1,117
Exercise price
Footnotes
F7, F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Christopher H. Hunter is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 10 footnotes

Footnote F1

Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant.

Footnote F2

Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21.

Footnote F3

Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22.

Footnote F4

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

Footnote F5

Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

Footnote F6

Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.

Footnote F7

Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

Footnote F8

Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21.

Footnote F9

Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Footnote F10

Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .